Tabex tablets film-coated

Страна: Армения

Език: английски

Източник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активна съставка:

cytisine

Предлага се от:

Sopharma JSC

АТС код:

N07BA04

INN (Международно Name):

cytisine

дозиране:

1,5mg

Лекарствена форма:

tablets film-coated

Броя в опаковка:

(100/5x20/) in blister

Вид предписание :

OTC

Статус Оторизация:

Registered

Дата Оторизация:

2018-02-07

Листовка

                                ,llu
cro
x-sxnaA
6ux
:
n
u
{ro
pu
a
u
u
rr,urfl
no.rpe6
urclr
Ta6erco
l
15
*t
r
ra6J'IerKrr,
n
oKp
r,rrbte
n.le
g
oq
tr
o
ii
o6o,ro.lror-r
TabexrE
1,5
rng
film-coated
tablets
uHrH3!lH
(cytisine)
flpovrrrre
BH[iuareJrbtro
Becb
JIIIc'ror(-BKJIrrAr'rru,
TaK
r(nx
ou
coAer)a{rr.r.
Ba?Kryro
a.nn
Bac
uurlropnaqrrrc.
3ror
lexapcrseHHltfi
npenapar
ornycxaercrr
6es
peuenra
Bpaqa.
Hectrorpa
ua
3ro,
qro6lr
nonyq,Tb
caN.rbre
xopouue
pesyrbrarbl
reqeHH{,
Bsr
lolxcusr
.r.ulareabHo
co6,rroAart
}4gcrpyKl{}.lH
K
npH
t\teHeuHro
neKapcTBeFrHOrO
npenapaTa.
-
coxpauu're
3Tor
,'rHCToK-Br(,Taauru.
y
Bac
lto;rer
flo.{Br,rrr,cfl
geo6xoAl4yocrb
npollt4Tarb
ero
cHoBa.
-
Ecll't
Balt
Heo6xo.IluMa
,qononH!t'terbr{4,
uucf
oplrauu.rr
Hr}r
coBer,
c[pocHTe
Baurero
rpapl.raueura.
-
Ecltl
lro6oe
Hr
no6oqublx
AeiicrBHr-r
craHoBrrrc,
cepbe3HbrM
uru
Bur
3aNrerH.re
rpyr,e,
HeoIIHcaHHble
B
3Tol\'r
rHcrKe-BIUIagltule
no6ouHule
neficrnnr,
npoclrpr
yBe/lolvrarb
o6
:rov
Barrero
Bpaqa
HnH
Qapuaqeara.
B
:ro;n,[IIcrKe-BK,.Iaxbrrue:
l,
tlro
npe.qcraBrrer
co6ofi
-fa6exc
H
Arrrr
qero
Hcno.rtb3yerc,
2.
Yro
Haao
3Harb
nepeA
npueMotu
Ta6exc
3.
Kax
npuunlrarr
Ta6erc
4.
Borr.roxnureno6oqHr,re.4eficrs!.ts
5.
Kar
coxpaH.mu
Ta6exc
6.
CoAepxaune
ynaKoBKH
H
AonoJrHHrenbHa,
nH$opuauar
tiFiS
,r0ll
I
ri$
$Y:r.iltriI
ist
:/iil
A-
'r.J
f,.'
li
i{
I
A
li
i
/
u
A
1
A-
l.
trro
npercraBJlrrer
co6or-l
Ta6enc
'gfla
qcro
rrc,.or.rr,3yer.crr
Ta6exc
coAep)KHT
aKTl.jBHoe
BeurecrBo
ullru
noro6,o,,
io'r,y.
np
ueru
ra6enc
BeAer
K
ili;Xiffili,iffJ^ffi
xl,":HJJ[;Iffi?il?",
HenpHrrltbtx
oiqyuleHHfi
u
aucnourbopra.
cBfl3aHHbrx
c
orrca3oi\,r
cHfaper..
Ta6erc
ltcno.,Ib3yerc.r
y
liogeli,
3aB]lcHI\,Llx
or
ra6axorvpeHur
(xponaqecxlrfi
ra6arn:;r),
Koropbte
xeJraroT
oTKa3aTbcfl
oT Hero.
2,
r{ro
u:lAo
3Harb
flepeA
rrprretron.r
Ta6enc
He
npuueurirre
Ta6enc
-
ecrll
y
Bac
a'lneprnn
(runepuyBcrBarelbHocru)
x
axruaHoil,ry
BeuecrBy
uH.rH3HH lr.qx
1rc6oil
r.r3
BcnoNloraTeribHblx
Beu{ecTB
nexapcTBeHHOrO
CpeACl.Ba;
-
H€AaBHo
nepeHecenartti
NurirapKT
MHoKapaa
Hnl,
&ro3roBoii
yaap,
secra6uasua,
creHo5apAHrr,
Hap
                                
                                Прочетете целия документ
                                
                            

Данни за продукта

                                I.
HA3BAHHEJIEKAPCTBEH}IOTONPEIAPATA
Ta6erc@
1,5
urra6nerru,
norpllrbr€
nreHo.rHofi
o6onoqxofi
Tabexo
1.5
mg
film-coated
tablets
":!
t^
'
:.,
!
i
i,',l
1lil*
2.
KAqECTBEHHbIfrrIKOJII{ITECTBEHHI,TfrCOCTAB
B
xaxinofi
ra6lerxe
coAep)*nrcq
qHTH3HH
(cytisine)
1,5
nrr
(e
rloprvre
l0o%)
.
BcnoMonareruHsre
eeulecrga
c
Hesecruu[,{
nefcre]reN{:
JraKro3a
u
Apyrue.
Ilonusrfi
cnncox
BcnoMorarerbr.tblx
Beulecrg
npeAcragJrex
a
nyum:e
6.1.
3.
"IEKr\PCTBtrI]I{ATIOOPMA
Ta6,i
erxa,
no
Kpbtrafl
nr
erloq
Hoii
o6oroq
xofi
.
I(pyr,rsle,
.&BortioBbtnyK,rste
6exesste'ra6,tetxlr,
noKpbn'bre
o6oaoqxofi,
gNauerlrov
6
r.tt.r.
4.
I{JIIIHIITIECIfl{EAAI{IIbItr
4.1
Tepanenru.recKuetroKa3arrufl
Xpouxuecxufi
r'ruxorn
nusru
(ra6arusrur
)
*,an,
orrca3a
or
ra6axorypeHHr.
4.2
!,o:lrponra
u
cnoco6 fipulreHenlrrr
4osHposxa
Bspoctue
fipenapar
npHl\'IeHrerc,
no
crery],onter"r
cxeN{e:
o'r
I
lo
3
,lns
-
no
I ra6lerxe
qepe3
Z
,wca
(6
ra6lerox
e
Aeuu)'
B
reqetrue
:rux
AHeit
o)Karaercl
nocreneHHoe
yrvrer{btueHHe
qucJra
BblKype;rsbrx
cHl-aper.
Ecllt
pe:y,rrrar
HeyloB.flerBopxTerbHbrfi,
leueHHe
npexpauaercfl
H
rrepe3
2-3
rvrecsqa
lvloxHo
Haqarb
ero
cHoBa.
flpr,r
xopou.rel,t
eo:aeficrel.lu
JrerreHHe
fipoAon]Kaercs
no
cleA)iroulefi
CKEME:
or
4
lo
12
lns
-
no
I
'ra6rerKe
Lrepe3
2,5
uaca
(5
ra6lerox
B
AeHb);
or
i3
ao
i6
lus
-
no
I
ra6rerKe
qepe:
3
qaca
(4
ra6nerxu
B
AeHb);
or
l7
eo
20
gu.s
-
no
I ta6lerxe
qepe3
5
qacoa
(3
ra6,relxn
B
Aer.rb);
or
2
I
ao
25
tns
-
no
l
-2
ra6lernn
B
AeHb.
[f
cduu
n?
u
u
e
cxcw
n
o
t
t)t
tn
utn
Ee:onacnocru
u
e$rlexrnBHocrb
Ta6exc
y
Aerefi
H
noApocrr(os
ao
I
B-rernero
Bo3pacra
He
)'cTaHoBneHa.
l7
u
t
1tre
t
t
t
tt
t
t
c
ttt
up
utc
6
5
-.
tc
D
t
r
te,,o
Goip.tc
n
ta
Ee3orracuocrr,
u
arfQenruBHocrb
Ta6ercc
y
nauueHroB
crapue
65
,rer
He
ycraHoBnehra.
Cnoco6
npumeHeuxx
Ta6lerxu
npHHHMalor
BH)T
pb
ueJ'rl,lr\,rH,
3anHBag
aocraroqHbrr{
K0JIH(recrBol\{
r(Hnxocrlr.
flpcxonxr
ltreJr
bHocrb
relleHH
rr
(corlacHo
cxem
e),
OxosqateluHoe
npeKpaueHHe
KypeHlrfl
ror)riHo
npor3or-rrri
K
nrroi\ry
Alro
c
HaqaJIa
J,leqer-rHr,
llocne
3aBeptIIeHltll
leqe6nor
                                
                                Прочетете целия документ
                                
                            

Сигнали за търсене, свързани с този продукт

Преглед на историята на документите